Generated by AI
Zoetis Inc. Class A Common Stock represents Zoetis, a global animal health company focused on medicines, vaccines, diagnostics, and related technologies for pets and livestock. Zoetis develops and markets products used by veterinarians, livestock producers, and pet owners across companion animals such as dogs, cats, and horses, as well as livestock including cattle, swine, poultry, fish, and sheep. Its portfolio includes parasiticides, dermatology treatments, pain and sedation products, anti-infectives, diagnostic tools, genetic tests, and precision animal health solutions. The company also provides reference laboratory services, rapid tests, instruments, and other non-pharmaceutical offerings that support disease detection and animal care. Headquartered in Parsippany, New Jersey, Zoetis operates in the United States and international markets, serving a broad range of animal health needs across clinical, agricultural, and diagnostic settings.
Website10 Sylvan Way
Parsippany, NJ, 07054
United States
The latest articles about ZTS.
More players enter growing market as domestic spending per animal rises
Summary of Nov 2's posts. Generated by AI.
Summary of Jul 21's posts. Generated by AI.
Summary of Jun 9's posts. Generated by AI.
Summary of Oct 6's posts. Generated by AI.
Investors talking about ZTS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.